Envista Holdings Corp chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 15.77
Dividend & YieldN/A$ (N/A)
Beta 1.43
Market capitalization 6.48B
Operating cash flow 182.7M
ESG Scores unknown

Company description

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio1.3
Working Capital0.54
Return On Equity0.08
Debt To Equity0.22
Fixed Asset Ratio0.2
Fixed Interest Cover7.08

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities -16.8M -69.8M -79.3M 15.5M
Total Cashflows From Investing Activities -78.4M -69.1M 262.7M -657.3M
Net Borrowings 1.32B 517.3M -475.7M -200k
Total Cash From Financing Activities -107.7M 492.5M -465.6M 12.5M
Change To Operating Activities -1.1M -29.2M -14.7M -176.3M
Issuance Of Stock 643.4M 13.8M 19.5M 21.8M
Net Income 217.6M 33.3M 340.5M 243.1M
Change In Cash 211.2M 677.7M 184.7M -466.7M
Effect Of Exchange Rate -200k -29.6M 26M -4.6M
Total Cash From Operating Activities 397.5M 283.9M 361.6M 182.7M
Depreciation 168.1M 163.1M 151.9M 162.1M
Change To Account Receivables 3.3M 71.9M -43.2M -71M
Other Cashflows From Financing Activities -2.07B -33.6M -2.2M
Change To Netincome 27.9M 89.3M 49.1M 45.1M
Capital Expenditures -77.8M -47.7M -54.7M -75.7M

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development 133.1M 86.7M 100.5M 100.1M
Income Before Tax 233.7M -20M 254.5M 283.9M
Net Income 217.6M 33.3M 340.5M 243.1M
Selling General Administrative 970.1M 858.8M 989.5M 1.03B
Gross Profit 1.35B 1.07B 1.47B 1.49B
Ebit 248.5M 127.6M 383.2M 364.6M
Operating Income 248.5M 127.6M 383.2M 364.6M
Interest Expense -3.5M -62.5M -54.1M -38.4M
Income Tax Expense 49.6M -62.5M -9M 45.9M
Total Revenue 2.28B 1.93B 2.51B 2.57B
Cost Of Revenue 933.1M 856M 1.04B 1.08B
Total Other Income ExpenseNet -14.8M -147.6M -128.7M -80.7M
Net Income From Continuing Ops 184.1M 42.5M 263.5M 238M
Net Income Applicable To Common Shares 217.6M 33.3M 340.5M 243.1M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 2.62B 3.15B 2.52B 2.38B
Total Stockholder Equity 3.54B 3.72B 4.06B 4.21B
Other Current Liabilities 236.5M 356.4M 296.4M 232.7M
Total Assets 6.16B 6.88B 6.57B 6.59B
Common Stock 1.6M 1.6M 1.6M 1.6M
Other Current Assets 100k 113.9M 12.2M
Retained Earnings 93.1M 126.4M 466.9M 731.4M
Treasury Stock -144.2M -91.8M -143.5M -225.1M
Cash 211.2M 888.9M 1.07B 606.9M
Total Current Liabilities 709.2M 1.68B 1.21B 1.24B
Other Stockholder Equity -144.2M -91.8M -143.5M -225.1M
Property, Plant, and Equipment 490.4M 437.3M 392.2M 425.4M
Total Current Assets 1B 1.59B 1.84B 1.42B
Net Tangible Assets -1.05B -639.5M -120.8M -376.4M
Net Receivables 443.6M 301.7M 331.9M 393.5M
Accounts Payable 208M 202.5M 185.8M 228.3M


Insider Transactions

Here are the insider transactions of stock shares related to Envista Holdings Corp:

Filer Name Transaction Text Ownership Date Filer Relation Shares
YU HOWARD HSale at price 37.90 per share.D2023-02-28Chief Financial Officer10.02k
AGHDAEI AMIRStock Award(Grant) at price 0.00 per share.D2023-02-24Chief Executive Officer27.19k
NANCE MARK EStock Award(Grant) at price 0.00 per share.D2023-02-24General Counsel6.21k
YU HOWARD HStock Award(Grant) at price 0.00 per share.D2023-02-24Chief Financial Officer10.29k
REIS MISCHAStock Award(Grant) at price 0.00 per share.D2023-02-24Officer4.58k
ERIKSSON PATRIKStock Award(Grant) at price 0.00 per share.D2023-02-24Officer5.56k
KYRILLOS JEAN-CLAUDEStock Award(Grant) at price 0.00 per share.D2023-02-24Officer5.56k
CONLEY ERICStock Award(Grant) at price 0.00 per share.D2023-02-24Officer21.57k
YU HOWARD HSale at price 36.55 per share.D2022-11-17Chief Financial Officer657
GALLAHUE KIERAN T.Stock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
RASKAS DANIEL AStock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
TSINGOS CHRISTINE AStock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
JAIN VIVEKStock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
CARRUTHERS WENDYStock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
HULIT BARBARA BStock Award(Grant) at price 0.00 per share.D2022-05-24Director4.43k
HUENNEKENS R SCOTTStock Award(Grant) at price 0.00 per share.D2022-05-24Director5.93k
YU HOWARD HSale at price 45.73 per share.D2022-04-18Chief Financial Officer5.34k
AGHDAEI AMIRSale at price 51.50 - 51.75 per share.D2022-03-29Chief Executive Officer10.54k
AGHDAEI AMIRSale at price 49.50 - 50.87 per share.D2022-03-21Chief Executive Officer125.24k
AGHDAEI AMIRConversion of Exercise of derivative security at price 16.51 per share.D2022-03-21Chief Executive Officer114.7k
YU HOWARD HSale at price 50.04 - 50.86 per share.D2022-03-21Chief Financial Officer24.54k
YU HOWARD HConversion of Exercise of derivative security at price 21.76 per share.D2022-03-21Chief Financial Officer24.54k
REIS MISCHASale at price 50.00 per share.D2022-03-18Officer10.09k
REIS MISCHAConversion of Exercise of derivative security at price 19.04 per share.D2022-03-18Officer10.09k
AGHDAEI AMIRSale at price 47.50 - 49.01 per share.D2022-03-17Chief Executive Officer128.75k
AGHDAEI AMIRConversion of Exercise of derivative security at price 15.27 - 16.51 per share.D2022-03-17Chief Executive Officer114.7k
BLUDWORTH CURT WSale at price 47.83 per share.D2022-03-01Officer4.18k
REIS MISCHASale at price 47.83 per share.D2022-03-01Officer2.96k
AGHDAEI AMIRStock Award(Grant) at price 0.00 per share.D2022-02-25Chief Executive Officer21.02k
NANCE MARK EStock Award(Grant) at price 0.00 per share.D2022-02-25General Counsel4.64k
YU HOWARD HStock Award(Grant) at price 0.00 per share.D2022-02-25Chief Financial Officer7.73k
YU HOWARD HSale at price 47.81 per share.D2022-02-25Chief Financial Officer3.6k
BLUDWORTH CURT WSale at price 47.71 per share.D2022-02-25Officer8.45k
REIS MISCHASale at price 47.59 per share.D2022-02-25Officer5.01k
REIS MISCHAConversion of Exercise of derivative security at price 16.51 per share.D2022-02-25Officer5.01k
REIS MISCHAStock Award(Grant) at price 0.00 per share.D2022-02-25Officer3.35k
REIS MISCHASale at price 47.71 per share.D2022-02-25Officer4.28k
ERIKSSON PATRIKStock Award(Grant) at price 0.00 per share.D2022-02-25Officer4.38k
MOORE KARI LYNStock Award(Grant) at price 0.00 per share.D2022-02-25Officer3.61k
KYRILLOS JEAN-CLAUDEStock Award(Grant) at price 0.00 per share.D2022-02-25Officer4.38k
REIS MISCHASale at price 47.50 per share.D2022-02-11Officer6.06k
REIS MISCHAConversion of Exercise of derivative security at price 19.04 per share.D2022-02-11Officer6.06k
AGHDAEI AMIRSale at price 46.75 - 46.78 per share.D2021-12-28Chief Executive Officer58.04k
AGHDAEI AMIRConversion of Exercise of derivative security at price 15.27 - 16.51 per share.D2021-12-28Chief Executive Officer29.7k
YU HOWARD HSale at price 45.07 per share.D2021-12-23Chief Financial Officer3.95k
YU HOWARD HConversion of Exercise of derivative security at price 19.49 per share.D2021-12-23Chief Financial Officer3.95k
BLUDWORTH CURT WSale at price 45.00 per share.D2021-12-23Officer13.35k
BLUDWORTH CURT WConversion of Exercise of derivative security at price 16.51 per share.D2021-12-23Officer13.35k
REIS MISCHASale at price 45.00 per share.D2021-12-23Officer10.02k
REIS MISCHAConversion of Exercise of derivative security at price 16.51 per share.D2021-12-23Officer10.02k
AGHDAEI AMIRSale at price 44.75 per share.D2021-12-22Chief Executive Officer8.43k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Envista Holdings Corp. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Envista Holdings Corp

Here is the result of two systematic investment strategies applied to Envista Holdings Corp. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Envista Holdings Corp

The following chart shows the equity curve of the two systematic investment strategies applied to Envista Holdings Corp:

Envista Holdings Corp automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 64.93% on the backtest period.

Performance at glance

Performance

64.93 %

Latent gain

647.47 $

Invested capital

997.17 $

Annualized return

30.63 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Envista Holdings Corp

This is the result of two momentum investment strategies applied to Envista Holdings Corp. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Envista Holdings Corp

The following chart shows all the entries opened by the momentum investment system on Envista Holdings Corp:

Envista Holdings Corp momentum entries
  • The first momentum investment strategy would give 69.5% of return on Envista Holdings Corp. That represents 1206.77$ of latent gain with 1736.27$ of employed capital.
  • The second momentum investment strategy would give 76.16% of return on Envista Holdings Corp. That represents 954.26$ of latent gain with 1253.02$ of employed capital.
Performance at glance (1Q Momentum)

Performance

69.5 %

Latent gain

1206.77 $

Invested capital

1736.27 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

76.16 %

Latent gain

954.26 $

Invested capital

1253.02 $

Annualized return

46.44 %

Momentum equity curve on Envista Holdings Corp

The following chart shows the equity curve of the two momentum strategies applied to Envista Holdings Corp:

Envista Holdings Corp momentum equity

Note: the dividends potentially given by Envista Holdings Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Envista Holdings Corp

The following chart shows the employed capital evolution of the two momentum strategies on Envista Holdings Corp since the beginning:

Envista Holdings Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Envista Holdings Corp

Buy the dip entry openings on Envista Holdings Corp

Envista Holdings Corp

The performance achieved by the robo-advisor on Envista Holdings Corp is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Envista Holdings Corp stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Envista Holdings Corp, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Envista Holdings Corp

The following chart shows the result of the investment strategy applied to Envista Holdings Corp:

Envista Holdings Corp

Note: the dividends potentially given by Envista Holdings Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Envista Holdings Corp

The following chart shows the employed capital evolution since the beginning of the investment strategy on Envista Holdings Corp:

Envista Holdings Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Envista Holdings Corp

In this section, I will compare the three previous investment strategies applied to Envista Holdings Corp.

Equity curve comparison on Envista Holdings Corp

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Envista Holdings Corp investment strategy comparison

Employed capital comparison on Envista Holdings Corp

Envista Holdings Corp investment comparison

Performance comparison on Envista Holdings Corp

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 64.93% 647.47$ 997.17$ 30.63%
Momentum 1 quarter 69.5% 1206.77$ 1736.27$ 36.97%
Momentum 2 quarters 76.16% 954.26$ 1253.02$ 46.44%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

30.63 %

Momentum 1Q

46.44 %

Momentum 2Q

46.44 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Envista Holdings Corp:

Positive correlations

Most correlated stocks this year

  • Envista Holdings Corp

  • Most correlated stocks last 3 months

  • NantHealth Inc
  • Envela Corp
  • Envista Holdings Corp
  • VanEck High Yield Muni ETF

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • SMCP
  • Immunovant Inc
  • PRODWAYS

  • Note: The algorithm computes the probability of correlation between Envista Holdings Corp and the other stocks. There may be false positives or some missing correlated stocks. If the price of Envista Holdings Corp does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Envista Holdings Corp
    Country United States
    City Brea
    Address Building E
    Phone 714 817 7000
    Website envistaco.com
    FullTime employees 12700
    Industry Medical Instruments & Supplies
    Sector Healthcare
    Exchange XNYS
    Ticker NVST
    Market www.nyse.com

    Envista Holdings Corp ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown